CytoDyn (CYDY) Interest Expenses (2010 - 2026)

CytoDyn's Interest Expenses history runs 17 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• Quarterly Interest Expenses rose 56.96% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1.8 million (down 77.81% YoY) and the FY2025 annual result came in at $126.2 million, up 110.68% from the prior year.
• Interest Expenses was $1.8 million for Q1 2026 at CytoDyn, down from $3.8 million in the prior quarter.
• Across five years, Interest Expenses topped out at $30.3 million in Q2 2025 and bottomed at $1.1 million in Q2 2022.
• A 5-year average of $6.6 million and a median of $3.0 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses sank 97.59% — and 2023, when it surged 1228.8%.
• CytoDyn's Interest Expenses stood at $3.3 million in 2022, then slumped by 65.07% to $1.2 million in 2023, then slipped by 0.26% to $1.2 million in 2024, then surged by 226.53% to $3.8 million in 2025, then tumbled by 52.68% to $1.8 million in 2026.
• Business Quant data shows CYDY's Interest Expenses at $1.8 million in Q1 2026, $3.8 million in Q4 2025, and $3.0 million in Q3 2025.